What distinguished the obesity-related changes in ESR2 expression compared with ESR1 in our study was that the decrease in ESR2 gene expression referred to visceral and subcutaneous adipose tissue depots. This evidence concerns the gene ESR1 and obesity due to melanocortin 4 receptor deficiency.